Device Trial Radar · NCT04229563
Post-Market Registry of AURYON Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease
Last checked: Nov 20, 2026Latest source record: May 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
102
Actual
Start
Aug 4, 2020
Primary completion
Mar 17, 2021
Study completion Apr 17, 2023
Sponsor
- Lead sponsor
- Angiodynamics, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 18, 2020
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The PATHFINDER Registry is a prospective, non-randomized, single arm, multicenter observational study. This pilot registry is aimed to evaluate the performance (peri-procedural) and clinical outcomes (intermediate and long-term) of the AURYON Atherectomy System, within the initial launch phase of the product in the market.
Conditions
- Infrainguinal Peripheral Artery Disease
- Peripheral Arterial Disease
- PAD
Interventions
AURYON Atherectomy SystemDevice
The AURYON Atherectomy System consists of two sub-units: 1) a single use catheter ("AURYON™ catheter"); and 2) a laser system.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Efficacy: Acute Procedural SuccessTime frame: Peri-procedural (by the end of the index procedure)
- Primary Safety: Freedom From Peri-procedural Major Adverse Events (PPMAE)Time frame: Through discharge, an average of 5 days
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Pulse Cardiovacular
Scottsdale, Arizona
Pima Vascular
Tucson, Arizona
Comprehensive Cardiovascular
Davenport, Florida
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.